ARCHIVES

Stereotactic Body Radiotherapy Could Improve Overall Survival

This article is from The Cancer Letter archive.

Vol. 34 No. 7 | July 29, 2011

Download PDF Visit The Full Archive

Related Articles

Panel Objects To Act Change Requiring NCI Carcinogen Report

May 12, 1978

Phase III Xtandi Trial Meets Primary Endpoints Of Progression-Free and Overall Survival

November 29, 2013

UPCI To Lead Clinical Trials Of Eli Lilly’s Oncology Agents.

July 6, 2001

Approvals and Applications: European Committee Signs Off On Paxene for KS reatment

March 5, 1999

In Brief: NCI’s Reorganization Plan Picks Up Speed In New Bureaucracy, Could Be Approved Soon

February 29, 1980

How the Institute Fared In House Markup: Chart

July 18, 1997